Natera Inc Stock
€145.00
Your prediction
Natera Inc Stock
Pros and Cons of Natera Inc in the next few years
Pros
Cons
Performance of Natera Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Natera Inc | -0.680% | 3.546% | 7.353% | 41.748% | -3.947% | 314.773% | - |
SI-BONE Inc | 2.450% | 0.610% | 1.227% | 34.146% | 26.923% | - | - |
Orasure Tech | -1.590% | -1.600% | 6.957% | -44.091% | -28.070% | -12.143% | -73.548% |
scPharmaceuticals | 1.220% | 13.046% | 52.687% | 0.756% | 6.975% | -21.584% | -51.861% |
News

Natera Stock: Insider Sales Cast Shadow on Growth
Natera's stock has rewarded investors with an impressive 60% gain over the past twelve months, but recent insider transactions have raised eyebrows despite strong operational performance. On April

27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
Stanley Druckenmiller is in an elite league of investors that includes the likes of Warren Buffett. He ran his hedge fund firm, Duquesne Capital Management, for 30 years, posting eye-popping average

Natera Stock: Executives Sell Shares Amid Strong Performance
Natera, a medical laboratory company listed on NASDAQ with a market capitalization of €19.08 billion, recently saw several of its executives selling shares. CEO Steven Leonard sold company shares